HomeNewsBusinessEconomyGST Council meeting on October 12: Deadlock over borrowing options expected to be resolved

GST Council meeting on October 12: Deadlock over borrowing options expected to be resolved

In August, the Centre had proposed two options to states, to either borrow Rs 97,000 crore (on account of GST implementation) through a special window facilitated by the RBI or to borrow the complete shortfall of Rs 2.35 lakh crore (including Rs 1.38 lakh crore due to COVID) from the market

October 12, 2020 / 12:03 IST
Story continues below Advertisement

After failing to resolve the stalemate over the borrowing options to meet the revenue gap in the previous Goods and Services Tax (GST) Council meeting, a settlement is now expected at the GST Council meeting scheduled on October 12.

The Centre had provided the states with two borrowing options to solve the issue of compensation dues.

Story continues below Advertisement

The Centre said as many as 21 states opted to borrow Rs 97,000 crore to meet the GST revenue shortfall. Most of these states are ruled by the BJP or parties which have supported it on various issues.

As states are hard-pressed for finances to meet their expenditure, some states like Bihar want the issue of pending compensation dues worth over Rs 2 lakh crore to be settled at the earliest.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show